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OBJECTIVES: The objective of this paper was to characterize the population seen at the dentistry unit of the hematology-oncology 
service of the Oncology-Hematology Service, Instituto da Criança at the Hospital das Clínicas, Faculdade de Medicina, Univer-
sidade de São Paulo. Oral problems resulting from cancer therapy increase the risk of infection, length of hospital stay, treatment 
cost and negative impact on the course and prognosis of the disease. 
METHOD: Of the 367 medical records of cancer patients seen from November 2007 until December 2008: 186 with a cancer 
diagnosis and complete clinical data were selected, while 20 with a cancer diagnosis and incomplete records were excluded; 161 
medical records with only hematological diagnosis were also excluded. The following characteristics were assessed: ethnicity, 
gender, age, diagnosis and characteristics of the neoplasm, cancer therapy status and performed dental procedures. 
RESULTS: Review of 1,236 visits indicated that 54% (n=100) of the patients had blood cancers, 46% (n=86) had solid tumors and 
63% were undergoing anticancer therapy. The proportion of males (52.7%) in the study population was slightly greater. The most 
common cancer was acute lymphocytic leukemia (32.2%). Cancer occurred more often among those patients aged 5 to 9 years. The 
most common dental procedures were restorative treatment, preventive treatment and removal of infectious foci. 
CONCLUSION: The characteristics of the studied population were similar to those of the general Brazilian and global populations, 
especially regarding gender and diagnosis distributions. The aim of implementation of the dentistry unit was to maintain good oral 
health and patients’ quality of life, which is critical to provide oral care and prevent future oral problems. 
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INTRODUCTION
Established in 2007, the dentistry unit of the Oncology-
Hematology service of the Child’s Institute at the Hospital 
das Clínicas, Faculdade de Medicina, Universidade de São 
Paulo (ICr/HCFMUSP), sees patients aged from birth until 
young adulthood who are undergoing cancer therapy. The 
unit also provides care to patients with blood diseases, such 
as congenital or acquired anemia and platelet disorders.
Oral problems resulting from cancer therapy increase the 
risk of infection, length of hospital stay, treatment cost and 
negative impact on the course and prognosis of the disease.1
In addition to periodical visits to the ward, the dentistry 
team focus on preventive actions and dental treatment before, 
during and after chemo- or radiotherapy. The objective of 
their work is to prevent infections, maintain oral hygiene and 
minimize the adverse effects of anticancer therapies. 
In addition to these objectives, the unit acts as a reference 
center for the development of research, such as that reported 
here. The goal of this retrospective study is to characterize 
the population treated at a dentistry unit in a pediatric 
oncology teaching hospital.570
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MATERIAL AND METHOD
 
Of the 367 medical records of dental unit patients seen 
in the 14-month study period (from November 2007 to 
December 2008), 186 with a cancer diagnosis and complete 
clinical data were selected; 20 with a cancer diagnosis and 
incomplete data were excluded and 161 medical records 
with only a hematological diagnosis were excluded. The 
following characteristics were assessed: ethnicity, gender, 
age, diagnosis, characteristics of the cancer, currently 
undergoing cancer therapy and dental procedures performed.
RESULTS
Evaluation of 1,236 appointments during the study 
period yielded the following observations: 
1. Diagnosis: 54% (n=100) of the patients had 
hematological malignancies, and 46% (n=86) of the patients 
had solid tumors. Most of the patients (n=117) (63%) 
were undergoing cancer therapy. Figure 1 shows the most 
prevalent types of cancer in the study population. Table 
1 shows the distribution of the types of cancer diagnosis 
identified in the 186 patients. There is a clear prevalence of 
acute lymphocytic leukemia (32.2%) and leukemia (Table 1). 
2. Gender and age: A slight increase in males (52.7%) 
compared to females (47.3%) was observed (Figure 2). The 
pediatric age groups most commonly affected by cancer 
are children aged 5 to 8 years, followed by those patients 
aged 10 to 14 years and finally those patients aged 0 to 
4 years (Figure 2). The distribution of cancer prevalence 
related to gender was also evaluated (Figure 3). Males were 
more affected compared to females in the most prevalent 
childhood cancer (leukemias, lymphomas and tumors of 
the central nervous system). Figure 4 shows that the most 
common cancers among children aged 5 to 9 years are 
leukemias, lymphomas and tumors of the central nervous 
system. 
Table 1 - Diagnoses of the study population.
Diagnosis N. of patients %
 Leukemias (general) 71 38.2
Acute Lymphocytic Leukemia 60 32.2
CNS tumors 21 11.3
Lymphomas  20 10.8
Neuroblastoma 13 6.9
Retinoblastoma 9 4.8
RMS 9 4.8
Wilms´ tumor 8 4.3
Osteosarcoma 8 4.3
Histiocytosis 6 3.2
Lymphoepithelioma 4 2.1
Thyroid cancer 2 1
Nasal angiofibroma 2 1
Mesenchymal tumors 2 1
Ewing’s sarcoma 6 3.2
Other 8 4.3
Total 186 100
Figure 1 - The most prevalent childhood and adolescent cancer diagnoses 
in the studied population.
Figure 2 - A: The prevalence of the genders in the studied population. B: 
The prevalence of the pediatric age groups most commonly affected by each 
cancer type in the studied population. 
Figure 3 - The distribution of gender among the most prevalent childhood 
and adolescent cancer diagnoses in the studied population. 571
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3. Dental procedures: The most common dental 
procedures among the study population were restorative 
treatment, preventive procedures (prophylaxis, fluoride and 
oral hygiene), and removal of infectious foci (Figure 5).
DISCUSSION
The recently established Dentistry Unit in our Oncology-
Hematology Service optimized the care provided to patients 
and provided better interaction and close cooperation 
between the dental and medical teams, benefiting the patients 
and their families. 
This specialized unit is essential in Brazilian hospital 
settings because more than 9,000 new childhood cancers 
are diagnosed annually in Brazil. Cancer is the third leading 
cause of death in the 1- to 19-year-old age group in this 
country, behind accidents and violence.2 
The types of cancers that affect children under 15 
years of age are distinct from those that affect adults.3 The 
literature reports that during childhood, acute lymphocytic 
leukemia  (ALL)  is  the  most  common  malignancy, 
representing 24% of all childhood malignancies4-6 and 75% 
of all childhood leukemias.7 The findings of this study are 
consistent with the data presented in the literature. In our 
study ALL represents 84.7% of all leukemias and 32.2% of 
all childhood malignancies. 
The 0- to 4-year-old age group is cited as the age group 
most frequently affected by cancers. In this study, most 
(56.5%) of the cancer patients were aged 5 to 14 years.
In Brazil, leukemia predominates in the 1- to 4-year-old 
age group (31.6%), lymphoma is dominant in the 15- to 
18-year-old age group (35.6%), and tumors of the central 
nervous system have a similar prevalence (26%) in all 
patients under 14 years (1 to 4, 5 to 9 and 10 to 14 years).2 
The results of this study show that the most common 
malignancies in the 5- to 9-year-old age group were 
leukemias, lymphomas and tumors of the central nervous 
system. This finding should be further investigated in a 
more diverse patient population to avoid bias introduced 
by selection of patients from a pediatric oncology teaching 
hospital.
Regarding the comparison between genders, this study 
and other related studies,8 agree that general tumors, 
leukemias, lymphomas and tumors of the central nervous 
system are more prevalent in males than in females. 
Many  authors  9-11 report  that  the  most  common 
complications of pediatric cancer therapy are mucositis, 
xerostomia, bleeding, dysguesia, widening of the periodontal 
ligament space and infections (including bacterial, 
fungal and viral). These complications cause pain and 
discomfort, require parental narcotic therapy and extended 
hospitalizations, increase costs, and interfere with the course 
and prognosis of the neoplasm.12 
Dental abnormalities are the most common late 
complications in children subjected to cancer therapy; 
among these abnormalities are alterations of shape 
(microdontia, macrodontia, taurodontia), number (anodontia) 
and root formation (root shortening and blunting of the 
roots, root stunting) of the teeth.13-15 Children who undergo 
head and neck radiotherapy may experience abnormalities 
in the growth and maturation of the craniofacial skeleton 
structures,16,17 which can cause severe cosmetic and 
functional sequelae that require surgical and orthodontic 
interventions.18 
In our study, 63% of the patients were undergoing cancer 
therapy, and 37% had finished their treatment; therefore, 
periodic dental follow-ups are essential in both groups to 
diagnose complications and intervene as early as possible 
during cancer therapy. Furthermore, orthodontic treatment 
provided by this unit may be necessary to prevent and treat 
the craniofacial abnormalities caused by cancer therapy. 
Another side effect of chemotherapy is a drop in blood 
cell count, which is generally seen 5 to 7 days after the 
beginning of each cycle and usually lasts for 14 days. The 
period during which the blood cell count is low varies 
according to the treatment protocol.19 
Figure 4 - The distribution of the most prevalent childhood and adolescent 
cancer diagnoses among the age groups in the studied population.
Figure 5 - Dental procedures performed in the studied population. 572
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For this reason, the oral cavities of all pediatric patients 
should be assessed before the beginning of cancer treatment 
whenever possible to eliminate potential infectious foci 
and dental infections.20,21 When time is limited for dental 
care before cancer therapy, treatment priorities should be 
infections, extractions, periodontal care and sources of 
irritation.19
During the 14-month study period, the most common 
dental procedures were restaurative treatment, preventive 
procedures and removal of infectious foci, given the 
poor heath of the patients before cancer therapy. The 
dental procedures and oral care are performed to provide 
information and prevent future oral complications. 
Another treatment that was used quite frequently was 
low-power laser therapy to minimize one of the most 
debilitating side effects of cancer therapy: oral mucositis. 
Oral mucositis is a debilitating consequence and 
dose-limiting factor of anticancer therapy. It manifests 
as a burning sensation in the oral mucosa that can 
evolve to edema, erythema with formation of ulcers and 
pseudomembranes. It results in frequent extreme pain that 
requires dietary changes and parenteral administration of 
analgesics.22 
An efficient treatment for prevention of the onset of 
mucositis has not been described in the literature. Treatment 
with a low-power laser has been used in many wound models 
to promote tissue regeneration23 and to effectively reduce the 
severity of mucositis in animal24-26 and human27-29 studies. 
This finding is in agreement with our clinical results. 
CONCLUSION
In conclusion, the studied population presented 
characteristics that are similar to characteristics of the 
general Brazilian and world populations, especially 
regarding gender and diagnosis among cancer patients. In 
our study population, the establishment of a dentistry unit 
was essential to provide necessary oral care and prevent 
future problems, with the aim of maintaining the patients’ 
oral health and improving quality of life.
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